On ECHEMI
Home > Drugs > Dalian Tianyu Pharmaceutical Co., Ltd.
Dalian Tianyu Pharmaceutical Co., Ltd.
  • Founded in:

    1997-09-16
  • Country:

    China China
  • Address:

    Houshi, Jinzhou District, Dalian City, Liaoning Province
  • Tax NO.:

    91210213241831622W
  • Registered Funds:

    7.01427 million yuan
  • Website:

  • Email:

Related Drugs
Ranitidine Hydrochloride for Injection
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

Inhibit gastric acid secretion

More

Inhibit gastric acid secretion

66357-59-3 49
Mountain Green Tea Antihypertensive Capsules
Mountain green tea.
Name Description Content CAS NO. Registered Holders
FOLIUM ILICIS HAINANENSIS

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Zhengxin Thai Tablets
Astragalus, Pueraria, mistletoe, Salvia miltiorrhiza, hawthorn, and Ligusticum chuanxiong.
Name Description Content CAS NO. Registered Holders
Astragali Radix

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

0
Puerariae Lobatae Radix

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

0
Visci Herba

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

0
Salvia Root P.E Tanshinone IIA 20%

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

0
Hawthorn

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

0
Riligustilide

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

More

It is suitable for patients with coronary heart disease and angina pectoris with symptoms of qi deficiency and blood stasis or kidney deficiency. Symptoms include chest pain, chest tightness, palpitations, fatigue, dizziness, soreness of waist and knees, etc.

89354-45-0 0
Calcium Folinate and Sodium Chloride Injection
Main ingredient: Calcium folinate. Chemical name: N-[4-[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pterydinyl)methyl]amino]benzoyl-L-glutamic acid calcium salt pentahydrate.
Name Description Content CAS NO. Registered Holders
Calcium folinatc

This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It inhibits the synthesis of DNZ. After entering the body, this product is converted into tetrahydrofolate by tetrahydrofolate reductase, which can effectively counteract the toxic reaction caused by methotrexate, but has no obvious effect on the existing methotrexate neurotoxicity.

More

This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It inhibits the synthesis of DNZ. After entering the body, this product is converted into tetrahydrofolate by tetrahydrofolate reductase, which can effectively counteract the toxic reaction caused by methotrexate, but has no obvious effect on the existing methotrexate neurotoxicity.

6035-45-6 6
Ozagrel Sodium for Injection
Ozagrel sodium.
Name Description Content CAS NO. Registered Holders
Ozagrel sodium

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

More

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

189224-26-8 10
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.